🔗 Share this article

Treasury head Reeves has stated she is preparing "targeted action to address cost of living pressures" in the forthcoming financial statement.

During an interview with media outlets, she noted that lowering inflation is a collective task of both the administration and the central bank.

The United Kingdom's inflation rate is expected to be the highest among the Group of Seven industrialized countries this year and next.

Potential Energy Cost Interventions

It is understood the government could take action to bring down utility costs, such as by reducing the current 5% level of value-added tax charged on energy.

Another possibility is to reduce some of the regulatory levies currently added to bills.

Fiscal Limitations and Analyst Predictions

The administration will receive the latest draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for these measures.

The expectation from the majority of analysts is that the Chancellor will have to declare tax rises or spending cuts in order to adhere to her declared fiscal targets.

Previously on the same day, calculations indicated there was a twenty-two billion pound gap for the Treasury chief to address, which is at the more modest range of projections.

"There's a collective task between the central bank and the administration to continue tackling some of the sources of price increases," the Chancellor informed the BBC in the US capital, at the annual meetings of the IMF and World Bank.

Tax Commitments and Global Issues

While much of the attention has been on likely tax increases, the chancellor said the most recent data from the fiscal watchdog had not altered her commitment to manifesto promises not to increase rates on income tax, VAT or National Insurance.

She blamed an "unpredictable global environment" with rising international and trade concerns for the fiscal revenue measures, probably to be focused on those "most able to pay."

International Economic Tensions

Addressing concerns about the UK's commercial links with the Asian nation she said: "Our national security invariably come first."

Recent statement by China to strengthen export controls on rare earths and other resources that are key for advanced tech production led US President Donald Trump to suggest an additional 100% tariff on imports from the Asian country, increasing the possibility of an all-out commercial conflict between the two global powers.

The US Treasury Secretary called the Chinese move "economic coercion" and "a international production control attempt."

Questioned on accepting the US offer to join its dispute with China, Reeves said she was "deeply worried" by Chinese measures and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the decision was "harmful for the world economy and creates additional obstacles."

"It is my opinion there are sectors where we must confront Chinese policies, but there are also valuable opportunities to trade with Chinese markets, including banking sector and other areas of the economic system. We've got to maintain that equilibrium correct."

The Treasury chief also affirmed she was cooperating with international partners "regarding our own critical minerals strategy, so that we are reduced dependence."

Health Service Drug Pricing and Investment

The Chancellor also acknowledged that the cost the National Health Service pays for medicines could increase as a result of ongoing negotiations with the Trump administration and its drugs companies, in return for reduced taxes and capital.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or canceling projects in the United Kingdom, with some attributing the modest returns they are obtaining.

Last month, the Science Minister said the price the NHS pays for medicines would need to rise to stop businesses and drug research funding departing from the UK.

The Chancellor stated to media: "We have seen due to the payment system, that clinical trials, innovative medicines have not been provided in the UK in the manner that they are in other European countries."

"Our aim is to ensure that people receiving treatment from the National Health Service are can obtain the best critical treatments in the world. And so we are examining these issues, and... looking to obtain more investment into Britain."